top of page

Clinical Trials

Clinical trials play a vital role in improving eczema treatments and deepening our understanding of the condition. On this page, you'll find information about eczema-related clinical trials happening across Australia, including how to participate, what to expect, and who might be eligible. Whether you're considering taking part or simply want to stay informed, we're here to guide you every step of the way and help you make confident, informed decisions about your eczema care.
Momentum Inline Logo_Pine.png
Momentum Clinical Research NZ

Join a clinical trial for a new potential breakthrough treatment for Eczema. 

​

TrexBio Eczema Study

Researchers are assessing whether a potential new treatment can lessen the severity of eczema symptoms, strengthen the skin’s natural barrier, and provide lasting relief by targeting the underlying inflammation that causes itching and skin irritation.
If you are aged 18 to 70 years old and living with moderate-to-severe eczema that isn’t fully controlled by your current treatment, you may be eligible to take part.

​

Register your interest in this study at your nearest clinic and our team will be in touch. 

​

Pukekohe, Auckland   West Auckland   Kapiti    Nelson    Dunedin   


Huia Eczema Study
This study is investigating a potential new medication designed to target immune pathways involved in inflammation and itch associated with atopic dermatitis (eczema).
If you are aged 18 to 65 years old,  living with severe eczema and continue to experience persistent itch or skin inflammation, you may be eligible to take part.

​

Register your interest in this study at your nearest clinic and our team will be in touch. 

​

Takapuna Auckland    Kapiti   Palmerston North
 

Optimal Logo RGB 72dpi.jpg
Auckland Clinical Study

Eczema Itch: Non-Steroid Potential Medication

​

Eczema itch keeping you awake? If your current eczema meds aren’t enough, consider joining a clinical trial to test the suitability and effectiveness of a potential new, non-steroid topical medication.

​

This non-steroid option is not yet available at the pharmacy. It is hoped to potentially offer:

​

· Less itching, to help sleep and feel better

· Rapid itch relief

· A non-steroid option, with no steroid-type effects expected

​

 

Participants may get early access to the potential medication, receive study-related medical care at no cost, and compensation (up to $2350 NZD before tax) for completing participation. New Zealand Medicines and Medical Devices Safety Authority (MEDSAFE) and the Health and Disability Ethics Committee (HDEC) have given their approval for this study to run in New Zealand.

​

You might be eligible if all of the following apply to you:

​

· Aged 18 to 69 years (inclusive) 

· Diagnosed at least 6 months ago with Atopic Dermatitis (chronic eczema)

· Have persistent itching

· Aside from Atopic Dermatitis (Eczema), are in reasonably good health

· Live in Auckland or the wider Auckland region

· Other study criteria may apply

​

Click here to register your interest on the Optimal Clinical Trials website or call 0800 73 73 27 ext. 1

Feature Your Clinical Trial with EANZ

​

The Eczema Association New Zealand (EANZ) supports ethical, well-designed research that aims to improve outcomes for people living with eczema.

If you are a researcher, clinic, university, hospital, or clinical trial sponsor and would like to feature an eczema-related clinical trial on our website, we welcome you to get in touch.

Please refer to the media kit below for information on eligibility, requirements, and placement options, and complete the booking form to submit your clinical trial for consideration.

All submissions are reviewed to ensure alignment with EANZ’s values and community standards.

Disclaimer

The Eczema Association of New Zealand is sharing this clinical trial information for awareness purposes only.

We are not involved in the planning, conduct, recruitment, management, funding, or delivery of this clinical trial. Any questions about the trial, eligibility, participation, risks, benefits, or results should be directed to the clinical trial organisers or the listed study contact.

Sharing this information does not mean that the Eczema Association of New Zealand endorses, recommends, or guarantees the trial, treatment, product, or outcomes. Individuals should seek advice from their healthcare professional before making any decisions about participating in a clinical trial.

EANZ TransBG

The Eczema Association of New Zealand is committed to supporting those affected by eczema with resources, education, and support. Our mission is to empower individuals with eczema to lead healthier and more comfortable lives.

  • Instagram
  • Facebook
  • TikTok
  • Youtube
  • LinkedIn

help@eczema.org.nz

0800 300 182

Registered Charity: CC53042

© 2026 by The Eczema Association of New Zealand

All information provided by the Eczema Association is to give practical insights and help with eczema and its management for patients and the wider community.

​

Patch testing is always recommended before trying any new products. This information is not intended to constitute or replace medical advice, and is provided for general information purposes only. For medical advice, please always consult your health professional. Furthermore, it is not the policy of the Eczema Association to recommend or endorse any specific product, brand or treatment.

bottom of page